Page last updated: 2024-08-26

indolactam v and Breast Neoplasms

indolactam v has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acs, P; Ahmad, S; Blumberg, PM; Bogi, K; Glazer, RI; Kozikowski, AP; Lewin, NE; Ma, D; Modarres, S; Wang, S; Yao, J1
Basu, A1

Other Studies

2 other study(ies) available for indolactam v and Breast Neoplasms

ArticleYear
Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivit
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: Antineoplastic Agents; Binding Sites; Binding, Competitive; Breast Neoplasms; Cell Division; Crystallography, X-Ray; Enzyme Inhibitors; Female; Humans; Hydrogen Bonding; Indoles; Isoenzymes; Lactams; Lyngbya Toxins; Models, Molecular; Molecular Conformation; Molecular Structure; Mutagenesis, Site-Directed; Protein Kinase C; Tumor Cells, Cultured

1997
The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
    Molecular pharmacology, 1998, Volume: 53, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Bryostatins; Carcinogens; Enzyme Activation; Enzyme Inhibitors; Humans; Indoles; Isoenzymes; Lactams; Lactones; Macrolides; Maleimides; Phorbol 12,13-Dibutyrate; Protein Kinase C; Receptors, Tumor Necrosis Factor; Sensitivity and Specificity; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1998